Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Penny Stock Insider Trading

Tracking Executive Conviction in Stocks Under $5

Insider Activity in Low-Priced Equities

Insider trading in penny stocks often carries significant weight due to the high volatility inherent in smaller companies. When a director or CEO of a low-cap firm purchases shares, it can signal a major belief in an upcoming fundamental shift.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2026-02-20 19:33 2026-02-18 CNDT CONDUENT Inc Palau Hernandez Margarita Director Services-Business Services, NEC BUY $1.45 50,000 $72,650 50,000 +100.0%
2026-02-20 01:04 2026-02-17 NMRA Neumora Therapeutics, Inc. Milligan Michael Lee Officer - See Remarks Biological Products, (No Diagnostic Substances) SELL $3.57 1,436 -$5,119 21,034 -6.4%
2026-02-20 00:11 2026-02-11 SLQT SelectQuote, Inc. Grant Robert Clay Officer - PRESIDENT Insurance Agents, Brokers & Service BUY $0.88 118,901 $105,025 101,421 +100.0%
2026-02-20 00:11 2026-02-18 SEER Seer, Inc. Horn David R. Officer - PRESIDENT & CFO Laboratory Analytical Instruments SELL $1.99 7,743 -$15,447 501,262 -1.5%
2026-02-20 00:53 2026-02-18 ZIP ZIPRECRUITER, INC. SAKAMOTO RYAN T. Officer - EVP, Chief Legal Officer Services-Computer Programming, Data Processing, Etc. SELL $1.93 2,978 -$5,748 115,620 -2.5%
2026-02-20 00:06 2026-02-18 SEER Seer, Inc. Farokhzad Omid Director, Officer - CEO AND CHAIR Laboratory Analytical Instruments SELL $1.99 24,385 -$48,646 3,349,064 -0.7%
2026-02-20 00:48 2026-02-17 CMRC Commerce.com, Inc. Siminoff Ellen F Director, Officer - Executive Chair Services-Prepackaged Software BUY $2.94 100,000 $294,080 353,333 +39.5%
2026-02-20 01:05 2026-02-17 NMRA Neumora Therapeutics, Inc. BERNS PAUL L Director, Officer - See Remarks Biological Products, (No Diagnostic Substances) SELL $3.51 9,819 -$34,459 7,395,185 -0.1%
2026-02-20 04:56 2026-02-17 OM Outset Medical, Inc. Nash Marc Officer - EVP Operations R&D & Service Electromedical & Electrotherapeutic Apparatus SELL $3.35 1,817 -$6,087 39,988 -4.3%
2026-02-20 04:57 2026-02-17 OM Outset Medical, Inc. Trigg Leslie Director, Officer - Chair and CEO Electromedical & Electrotherapeutic Apparatus SELL $3.35 3,361 -$11,259 102,342 -3.2%
2026-02-20 04:57 2026-02-17 OM Outset Medical, Inc. Brottem John L. Officer - General Counsel Electromedical & Electrotherapeutic Apparatus SELL $3.35 2,842 -$9,521 32,935 -7.9%
2026-02-20 04:33 2026-02-17 PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Van Oene Mark Officer - See Remarks Laboratory Analytical Instruments SELL $1.59 184,897 -$294,319 1,742,638 -9.6%
2026-02-20 04:28 2026-02-17 PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Farmer Michele Officer - See Remarks Laboratory Analytical Instruments SELL $1.59 50,167 -$79,856 219,092 -18.6%
2026-02-20 04:31 2026-02-17 PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. HENRY CHRISTIAN O Officer - See Remarks Laboratory Analytical Instruments SELL $1.59 472,667 -$752,391 2,673,500 -15.0%
2026-02-20 03:57 2026-02-17 SNES SenesTech, Inc. GLENBROOK CAPITAL MANAGEMENT 10% owner Agricultural Chemicals BUY $2.34 85,901 $200,639 704,211 +13.9%
2026-02-20 03:30 2026-02-18 RXRX RECURSION PHARMACEUTICALS, INC. Taylor Ben R Officer - Chief Financial Officer Biological Products, (No Diagnostic Substances) SELL $3.08 13,426 -$41,352 1,195,349 -1.1%
2026-02-20 03:30 2026-02-19 RXRX RECURSION PHARMACEUTICALS, INC. Gibson Christopher Director Biological Products, (No Diagnostic Substances) SELL $3.46 40,000 -$138,400 906,556 -4.2%
2026-02-20 03:12 2026-02-17 HNGE Hinge Health, Inc. Robinson Elliott Director, 10% owner Services-Computer Processing & Data Preparation SELL $0.00 0 $0 0 -100.0%
2026-02-20 03:00 2026-02-17 SNAP Snap Inc Briers Zachary M Officer - General Counsel Services-Computer Programming, Data Processing, Etc. SELL $4.71 203,325 -$958,128 2,785,468 -6.8%
2026-02-20 03:00 2026-02-17 SNAP Snap Inc Mohan Ajit Officer - Chief Business Officer Services-Computer Programming, Data Processing, Etc. SELL $4.70 119,339 -$561,060 5,158,477 -2.3%
2026-02-20 03:00 2026-02-17 SNAP Snap Inc Andersen Derek Officer - Chief Financial Officer Services-Computer Programming, Data Processing, Etc. SELL $4.70 63,041 -$296,331 3,892,617 -1.6%
2026-02-20 03:00 2026-02-17 SNAP Snap Inc Morrow Rebecca Officer - Chief Accounting Officer Services-Computer Programming, Data Processing, Etc. SELL $4.72 19,674 -$92,938 463,507 -4.1%
2026-02-20 03:00 2026-02-17 BLIN Bridgeline Digital, Inc. Kahn Roger E. Director, Officer, 10% owner - President and CEO Services-Prepackaged Software BUY $0.78 54,301 $42,208 1,763,736 +3.2%
2026-02-20 02:40 2026-02-17 OPTU Optimum Communications, Inc. Olsen Michael Officer - General Counsel and CCRO Cable & Other Pay Television Services SELL $1.60 250,000 -$400,000 1,496,277 -14.3%
2026-02-20 02:46 2026-02-10 CBDS Dogecoin Cash, Inc. TOBIAS DAVID Director, Officer, 10% owner - CEO Services-Personal Services SELL $0.02 435,000 -$8,004 25,393 -94.5%
2026-02-20 02:18 2026-02-17 LAW CS Disco, Inc. Herckis Karen Officer - EVP, Chief HR Officer Services-Prepackaged Software SELL $3.07 8,171 -$25,085 132,259 -5.8%
2026-02-20 02:19 2026-02-17 LAW CS Disco, Inc. Garcia Susan Officer - GC & Chief Compliance Officer Services-Prepackaged Software SELL $3.07 3,743 -$11,491 74,237 -4.8%
2026-02-20 02:20 2026-02-17 LAW CS Disco, Inc. Crum Richard Francis Officer - EVP, Chief Prod & Tech Officer Services-Prepackaged Software SELL $3.07 6,508 -$19,980 224,412 -2.8%
2026-02-20 02:21 2026-02-17 LAW CS Disco, Inc. Antoon Melanie Officer - EVP, Chief Customer Officer Services-Prepackaged Software SELL $3.07 9,289 -$28,517 203,421 -4.4%
2026-02-20 02:10 2026-02-18 GERN GERON CORP ROBERTSON MICHELLE Officer - EVP, CHIEF FINANCIAL OFFICER Pharmaceutical Preparations OPT+S $1.94 9,855 -$19,119 17,645 0.0%
2026-02-20 01:55 2026-02-17 OPEN Opendoor Technologies Inc. Schwartz Christina Officer - Chief Financial Officer Real Estate Agents & Managers (For Others) SELL $4.32 74,248 -$320,633 3,844,214 -1.9%
2026-02-20 01:06 2026-02-17 NMRA Neumora Therapeutics, Inc. Pinto Joshua Officer - President Biological Products, (No Diagnostic Substances) SELL $3.54 5,967 -$21,093 57,783 -9.4%
2026-02-20 01:07 2026-02-17 NMRA Neumora Therapeutics, Inc. Aurora Daljit Singh Officer - See Remarks Biological Products, (No Diagnostic Substances) SELL $3.56 6,165 -$21,917 82,770 -6.9%
2026-02-20 00:39 2026-02-17 NOTV Inotiv, Inc. Leasure Robert Jr. Director, Officer - President and CEO Services-Commercial Physical & Biological Research SELL $0.30 16,810 -$4,964 1,256,215 -1.3%
2026-02-20 00:40 2026-02-17 NOTV Inotiv, Inc. Sagartz John E Officer - Chief Strategy Officer Services-Commercial Physical & Biological Research SELL $0.29 2,119 -$616 735,697 -0.3%
2026-02-20 00:41 2026-02-17 NOTV Inotiv, Inc. Taylor Beth A. Officer - Chief Financial Officer Services-Commercial Physical & Biological Research SELL $0.29 2,888 -$846 145,480 -1.9%
2026-02-20 00:30 2026-02-18 DTIL PRECISION BIOSCIENCES INC SMITH J. JEFFERSON Officer - Chief Research Officer Biological Products, (No Diagnostic Substances) OPT+S $3.84 4,925 -$18,912 121,926 0.0%
2026-02-20 00:30 2026-02-18 DTIL PRECISION BIOSCIENCES INC Scimeca Dario Officer - General Counsel and Secretary Biological Products, (No Diagnostic Substances) OPT+S $3.84 4,925 -$18,912 56,457 0.0%
2026-02-20 00:31 2026-02-18 DTIL PRECISION BIOSCIENCES INC Kelly John Alexander Officer - Chief Financial Officer Biological Products, (No Diagnostic Substances) OPT+S $3.84 8,149 -$31,292 125,883 0.0%
2026-02-20 00:31 2026-02-18 DTIL PRECISION BIOSCIENCES INC Amoroso Michael Director, Officer - President and CEO Biological Products, (No Diagnostic Substances) OPT+S $3.84 20,559 -$78,947 243,392 0.0%
2026-02-20 00:33 2026-02-18 GPRO GoPro, Inc. Stephen Jason Christopher Officer - SVP, General Counsel Photographic Equipment & Supplies SELL $0.80 5,393 -$4,300 134,542 -3.9%
2026-02-19 23:51 2026-02-18 TSI TCW STRATEGIC INCOME FUND INC McMillan Peter Director Other BUY $4.70 32,610 $153,267 250,000 +15.0%
2026-02-19 23:39 2026-02-19 XFLT XAI Octagon Floating Rate & Alternative Income Trust Spence John Yogi Officer - Vice President Other BUY $3.90 5,000 $19,500 561,792 +0.9%
2026-02-19 20:20 2026-02-18 RCG RENN Fund, Inc. STAHL MURRAY Officer, 10% owner - President/Co-Portfolio Manager Other BUY $2.75 1,134 $3,119 65,892 +1.8%
2026-02-19 19:51 2026-01-30 XSLLU Xsolla SPAC 1 Agapitov Aleksandr Director, 10% owner Blank Checks BUY $0.00 403,146 $0 403,146 +100.0%
2026-02-19 17:00 2026-02-18 SINT Sintx Technologies, Inc. Anderson Mark Lewis Director Surgical & Medical Instruments & Apparatus BUY $3.02 3,000 $9,060 18,000 +20.0%
2026-02-19 00:07 2025-09-04 VELO Velo3D, Inc. Lloyd Jason Michael Director Special Industry Machinery, NEC BUY $3.91 7,000 $27,390 13,376 +109.8%
2026-02-19 00:49 2026-02-13 UWMC UWM Holdings Corp Mat Ishbia Director, Officer, 10% owner - President and CEO Mortgage Bankers & Loan Correspondents SELL $4.89 1,898,622 -$9,284,262 6,495,029 -22.6%
2026-02-19 00:35 2026-02-17 MQ Marqeta, Inc. Sumner Crystal Officer - See Remarks Services-Prepackaged Software SELL $4.00 5,056 -$20,212 311,948 -1.6%
2026-02-19 00:33 2026-02-17 MQ Marqeta, Inc. Cummings Martha Director Services-Prepackaged Software SELL $4.00 2,853 -$11,410 38,969 -6.8%
SHOW ENTRIES

High Risk, High Reward Insider Trades

Penny stocks are notoriously volatile, but when insiders put their own money into stocks priced under $5, it provides a unique layer of validation. Unlike large-cap stocks where buys might be routine, a million-share purchase at $0.50 can indicate that management sees a path to recovery or exponential growth. Our tracking allows you to identify ini speculative signals in real-time, focusing on the capital flow of those with intimate industry knowledge. Following these low-cap moves helps bridge the information gap in the most volatile market segments.

Identifying Legitimate Micro-Cap Conviction

Our Penny Stock Filter isolates the most speculative yet promising filings from the SEC Form 4 feed. By focusing on low-priced equities, we highlight where CEOs and Directors are taking meaningful positions. This list is essential for small-cap investors looking to follow the capital of those with intimate knowledge of a company's research, patents, or upcoming regulatory approvals. Eliminate the noise and focus strictly on high-impact accumulation from leadership betting big on their company’s future value in the micro-cap space.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.